Previous Close | 145.04 |
Open | 152.28 |
Bid | 154.18 x 900 |
Ask | 154.00 x 1000 |
Day's Range | 148.54 - 155.05 |
52 Week Range | 102.22 - 260.46 |
Volume | |
Avg. Volume | 2,753,572 |
Market Cap | 55.259B |
Beta (5Y Monthly) | 1.07 |
PE Ratio (TTM) | 119.50 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.64 (1.82%) |
Ex-Dividend Date | Feb 28, 2024 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for EL
The S&P 500 closed out the week with modest gains on Thursday, with the benchmark index notching its strongest first quarter in five years, as investors digested the latest batch of economic data while looking towards the next inflation reading. Each of the three main U.S. indexes were set for solid quarterly gains, led by a climb of more than 10% for the S&P 500, aided by optimism over artificial intelligence (AI) related stocks and expectations the U.S. Federal Reserve will begin to cut interest rates this year.
Shares of beauty products company Estée Lauder (NYSE:EL) jumped 6.6% in the afternoon session after Bank of America upgraded the stock's rating from Neutral to Buy and raised the price target from $160 to $170. The new price target represents a potential 10% upside from where shares traded when the upgrade was announced. The analyst added, "In our view, EL has lost focus on product upgrades and innovation in recent years...Now, however, Estée Lauder is rolling out new derma lines, increasing its
**RH (RH)**: The furniture retailer forecast customer demand would pick up this year as interest rates ease. RH stock jumped 16%, on track for it highest close since September. **Walgreens Boots Alliance (WBA)**: The pharmacy giant booked a steep quarterly loss, reflecting a writedown on its VillageMD unit, but its adjusted earnings trumped Wall Street's expectations.